ArticleLeukemia & lymphoma2026
NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia.
John R Sanchez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it